We then analyzed the ability of ibrutinib to abrogate the pro-survival signal induced by IL-10 stimulation (1 ng/ml) in CLL cells after 24-48 hours of culture. This evidence concerns the gene IL10 and B-cell chronic lymphocytic leukemia.